Meyka AI API is live for developers.Start building.
Advertisement
Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) Stock Overview

Explore Harrow Health, Inc. 8.625% Senior Notes due 2026’s financial performance, market position, analyst ratings, and future outlook.

HROWL●NASDAQ
HealthcareMedical - Pharmaceuticals
$25.61
$0.05(0.19%)
U.S. Market is Open · 10:09
Advertisement

Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Meyka AI Score

Z

Key Financials

Market Cap1.4B
P/E Ratio-105.30
EPS (TTM)N/A
ROE-0.34%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$25.03

HROWL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $25.03.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -105.30 and a market capitalization of 1.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.20%
3-Month Change
0.83%
6-Month Change
1.39%
Year-to-Date (YTD) Change
1.23%
1-Year Change
1.43%
3-Year Change
8.52%
5-Year Change
2.89%
All-Time (Max) Change
2.89%

Contact Information

http://www.harrowinc.com
NaN
NaN, Nashville, DE, NaN

Company Facts

2,170 Employees
IPO DateMay 7, 2021
CountryUS

Frequently Asked Questions